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INTRODUCTION
1.1 Omics Technologies
During the last 50 years, the field of molecular biology underwent particular techno-
logical advances. This progress started with the discovery of the DNA double helix
and a most recent milestone was the completion of sequencing of the human genome.
Nowadays, high-throughput (HT) techniques are fully established in the daily rou-
tine in the labs, enabling the study of thousands of genes or proteins simultaneously.
The most popular techniques are microarrays but also other procedures like 2D gel
electrophoresis have widely expanded. These new technologies allow a more global
view on cellular processes on different levels of observation and can be embraced
by the term omics technologies, including genomics, transcriptomics, proteomics and
metabolomics, and many more.
The term ”omics” stands for the comprehensive analysis of the respective level
of biological systems, as proteomics refers to the study of the proteome of a cell in
a given state. Genomics attempts to describe a cell or an organism in terms of the
sequence of its genome, whereas transcriptomics examines gene expression on the
RNA level. The most recent subdiscipline is metabolomics, which aims to detect and
quantify the low molecular weight molecules known as metabolites.
As technical and experimental limitations restricted scientists to a purely
hypothesis-driven research, the progress of omics technologies enables a complemen-
tation with explorative, data-driven approaches. The rational behind an unbiased
analysis is that features of biological processes may be found in an initially unex-
pected context.
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2All these advances have induced a novel paradigm in molecular biology research:
• HT technologies allow a global and integrative insight into biological systems
and led to the development of systems biology as a multidisciplinary ap-
proach.
• The need of administration and interpretation of the increasing amount of het-
erogenous data, as derived from HT experiments, triggered the emergence of
the subdiscipline computational systems biology.
The next section provides an overview of the concepts of systems biology, as well
as of the subdiscipline computational systems biology.
31.2 Concepts of Systems Biology
The systems biology approach arises from the rational that properties of biological
systems cannot be reduced to those of their parts. The advance of omics technologies
has established a basis for integrative studies of biological processes on more than
one level of observation. Thus, generation, management, and interpretation of the
available data poses a multidisciplinary challenge.
The field of systems biology attempts to provide a systems-level understanding by
systematically organizing the different omics data, using it to build a descriptive and
mechanistic model of the underlying biological phenomena [1]. Systems modeling
of a physiological process beginning at the level of genes and gene networks is a
highly iterative process involving cycles of data collection, quantitative modeling,
hypothesis formulation and testing, and model refinement [2]. With the possibility to
generate quantitative data, a shift towards dynamic, quantitative models was induced.
Whereas qualitative biological models are in their nature discrete, the quantitative
approach tries to provide an understanding of the dynamical characteristics of the
whole system.
With these evolving concepts in systems biology, the integration of experimental
and computational research has become necessary. The management of the large
amount of data and the complex coherences between different levels of observations
require computational power. Protein as well as DNA sequence databases are growing
at steady pace. Examples are SWISSPROT [3], the Protein Data Bank (PDB) [4] or
the NCBI (National Center for Biotechnology Information) RefSeq [5]. Furthermore,
databases providing functional analysis tools have developed, including the protein
analysis through evolutionary relationships (PANTHER) classification system [6] and
the pathway databases KEGG (Kyoto Encyclopedia of Genes and Genomes) [7].
A further challenge is to resolve the problem of integrating heterogeneous data
from different sources with varying degrees of reliability. Functional mapping projects
have recently emerged, generating large-scale maps from functional omics data. The
4UBC Bioinformatics Center developed Atlas, a biological data warehouse that locally
stores and integrates biological sequences, molecular interactions, homology infor-
mation, functional annotations of genes, and biological ontologies [8]. Aerts et al.
designed a web tool named Endeavour, that prioritizes candidate genes underlying
biological processes or diseases, based on their similarity to known genes by combining
multiple data sources [9].
Of particular interest in context of data integration are protein-protein interactions.
Represented as molecular interaction networks, they can serve as a basis for analysis
of the dynamics of biological systems. An outline of the major concepts of protein
interaction networks and an overview of recent approaches is given in the following
section.
51.3 Protein Interaction Networks
Networks of molecular interactions are widely studied to reveal the complex roles
played by genes, gene products and the cellular environment in biological processes.
These networks can either represent direct physical binding of proteins, or functional
relationships between the involved objects. The former approach is widely covered
by protein interaction databases like OPHID [10], BIND [11], HPRD [12, 13], MIPS
[14] or the MINT database [15].
However, understanding biological processes equally requires knowledge of indirect
relationships. These can include shared pathway or process memberships, the same
cellular localization or similar tissue specific expression levels. Von Mering and col-
leagues developed the database STRING (Search Tool for the Retrieval of Interacting
Genes/Proteins) [16], holding interactions derived from high-throughput experimen-
tal data, from the mining of databases and literature, and from predictions based on
genomic context analysis. A further approach is a system designed by Myers et al. for
predicting process-specific networks, including information derived from microarray
data sets, protein-protein interactions, as well as sequence data [17].
Within this thesis, networks representing physical protein interactions, as well as
a dependency graph analysis were integrated in the applied workflows. Subjects
of study were two sets of gene expression data characterizing an animal model of
membranous nephropathy and pathophysiological processes encountered after trans-
plantation of cadaveric donor kidneys.
61.4 Kidney Diseases
In the recent years, a multitude of studies have been performed tackling a wide
range of kidney diseases. High-throughput technologies facilitated the identification
of relevant molecular mechanisms and protein biomarkers associated with common
kidney diseases. In this thesis, two different aspects of kidney diseases were analyzed.
The following subsections provide an overview of the pathophysiology of these diseases
as well as of the current status of protein biomarkers, identified in recent studies in
the context of acute renal failure (ARF) and chronic kidney disease (CKD).
1.4.1 Pathophysiology
Experimental Membranous Nephropathy
Membranous nephropathy (MN) is an antibody mediated and complement depen-
dent disease, which can lead to ARF as well as CKD. The target of injury in MN
is the glomerular visceral epithelial cell or podocyte, a highly specialized and ter-
minally differentiated cell that is located on the outside of the glomerular basement
membrane [18]. Binding of antibodies to membranous antigenes, identified as megalin
associated complexes [19], leads to complement activation and formation of subepithe-
lial immune deposits. The hallmarks of MN are thickening of the basement membrane
due to an increase in the accumulation of extracellular matrix protein synthesis by
injured podocytes and loss of the glomerular filtration barrier followed by proteinuria.
Passive Heymann Nephritis (PHN) is a rat model that shows similarity to human
MN. Rats are immunized with an antibody directed against the crude renal fraction
Fx1A that contains megalin as a principal component [20]. This animal model was
used as a basis for experimentally determining the gene expression pattern of glomeruli
in diseased rats for learning more on the pathophysiology of MN.
Renal Transplants
The incidence of end-stage renal disease increased over the last years. Kidney trans-
plantation is the treatment of choice for most of these patients, but the number of
7kidneys available for transplantation is limited [21]. More and more patients are
reliant on cadaveric donor kidneys, but clinical observations report severe organ in-
flammation, post-transplant ARF and a reduced long-term survival of transplants
when compared to patients recieving transplants from living donors.
The risc factors for a delayed graft function include donor age and cause of death,
the duration of cold ischemia, or intraoperative diuresis [22]. However, intrinsic donor
factors are main contributors to post-transplant ARF. Brain-death often leads to the
development of a central diabetes insipidus (excretion of large amounts of severely
diluted urine) and following dehydration, in turn causing arterial hypertension [23].
All of these mechanisms are risc factors for the development of post-transplant ARF.
Still, it remains unclear what specifically increases the propensity for the cadav-
eric renal graft to develop ARF after engraftment. To gain further insights in the
ongoing biological mechanisms, we analyzed the results of a gene expression analysis
comparing living and cadaveric donor kidney biopsies in context of functional depen-
dencies of differentially regulated genes, represented in a dependency graph of protein
interactions.
1.4.2 Biomarkers
As kidney diseases are major health problems with increasing incidence, the need
for identification of novel biomarkers for early diagnosis and prognosis is rising. A
frequently used marker for ARF in clinical practice is creatinine, but creatinine levels
do not change until loss of renal function has far progressed. Functional markers for
CKD are again creatinine or Cystatin C [24], both used to estimate the glomerular
filtration rate.
Over the last years, the pool of biomarker candidates could be extended by ex-
plorative analysis approaches, enabled by omics technologies. Due to the limitation
in number of samples, the false positive rate of potential markers is rather high and
requires further experimental verification steps.
Based on a literature review, Perco et al. [25] summarized protein markers reported
as associated with ARF and CKD. The underlying detection methods were partly
8hypothesis driven, executed as immunohistochemistry or western blot analysis, but
also results from microarray experiments were reported.
In view of the fact that biomarkers for early prognosis of renal failure are still
missing, further studies are essential to also accomplish the development of improved
therapeutic approaches.
91.5 Thesis Goals
The main purpose of this thesis was to identify relevant genes and potential biomark-
ers in context of kidney diseases by means of microarray technology and subsequent
bioinformatic analysis with focus on the mapping of gene expression data on protein
networks. In particular two different approaches were applied, namely a sequential
and an integrated analysis workflow. The aim of the sequential workflow was to
detect genes differentially regulated between healthy and passive heyman nephritis
induced rats. This workflow mainly rests on statistical data analysis. The integrated
workflow in contrast is based on a dependency graph approach representing a human
protein interaction network, and was applied to a set of differentially expressed genes
comparing living and cadaveric renal transplants.
MATERIAL
2.1 Experimental Membranous Nephropathy - The PHN
Dataset
Passive Heymann Nephritis (PHN) is a rat model that shows similarity to human
membranous nephropathy. It remains a valuable experimental tool because the func-
tional and immunohistological features closely resemble the human disease[26]. To
determine which known genes are transcriptionally up or down-regulated in PHN,
a gene expression analysis was performed by the group of Prof. Shankland at the
University of Washington, Seattle, WA, USA.
To induce passive Heymann nephritis twenty male Sprague-Dawley rats (Simson,
Gilroy, CA, USA) received a single intraperitoneal injection of sheep anti FX1A an-
tibody as described by Shankland et al.[27]. Twenty additional control animals were
injected with normal sheep serum. In order to assess proteinuria and renal function,
urine was collected by placing the animals in metabolic cages for 12 hours, during
which time water was supplied without restriction. Protein and creatinine excretions
were measured using the sulfosalicylic acid turbidity method[28] and a colorimetric
microplate assay based on the Jaffe reaction [29] (Oxford Biomedical Research, MI,
USA) respectively.
In each case, half of the animals were sacrificed after three and the other half
after six days. For glomeruli isolation, the kidney cortex was removed, minced and
pressed through sieves. Than, the glomeruli were collected and pelleted in phosphate
buffered saline by centrifugation. Subsequently, the total RNA was isolated, using
the TRIZOL method (Invitrogene Corp, Carlsbad, CA, USA). Quantity and OD
260/280 of total RNA and cRNA was assessed by UV spectrophotometry and cRNA
was labeled with Biotin according the Affymetrix eukaryotic target labeling protocol.
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The RNA of two animals was pooled and hybridized to one microarray, resulting
in five biological replicates for disease and control animals each at days 3 and 6.
The samples were hybridized on Affymetrix R230A GeneChip arrays according to
standard Affymetrix protocol.
The resulting raw data of the images was stored in .DAT files, the analysis in
.CHP files and probe set information in .CEL files. The latter, each holding 15924
probes and their corresponding intensity values, were further analyzed as described
in section3.1.
12
2.2 Renal Transplants - The LIV/CAD Dataset
A high percentage of cadaveric, but rarely living donor renal transplant recipients
develop postischemic acute renal failure (ARF). ARF patients tend to reduced long-
term allograft survival and acute rejection occurs more frequently [30]. To identify
regulatory pathways of ARF, a genome-wide expression analysis was performed by
the group of Prof. Oberbauer at the Medical University of Vienna.
The gene-expression pattern was determined in three classes of 32 donor kidney
biopsies: 12 living donor kidneys with primary function, 12 cadaveric donor kidneys
with primary function and 8 cadaveric donor kidneys with biopsy proven acute re-
nal failure. Immediately before transplantation, the wedge biopsies were obtained,
instantly submerged in RNAlaterTM (Ambion, Austin, TX, USA) and homogenized
[31]. Total RNA was isolated and purified with RNeasy columns (Qiagen, Hilden, Ger-
many). The RNA yield and quality was checked with the Agilent 2100 Bioanalyzer
and RNA6000 LabChip R© kit (Agilent, Palo Alto, CA, USA). Stratagene universal
human reference RNA was used as standard (Stratagene, La Jolla, CA, USA). Since
that the total amount of isolated RNA was very small, a T7 RNA amplification step
using the RiboAmp RNA amplification kit (Arcturus, Mountain View, CA, USA) was
necessary [32].
The samples were hybridized on cDNA arrays, obtained from the Stanford Uni-
versity Functional Genomics core facility, each holding 26338 genes and 14783 ESTs.
Preprocessing and further analysis steps were performed as described in sections 3.1
and 3.2.
METHODS
The following chapter describes the methods used for the analysis of the datasets,
generated as outlined in chapter 2. The first section reports the sequential analysis
workflow applied on the PHN, as well as on the LIV/CAD dataset. Section 2 provides
an overview of the dependency graph approach that was carried out to complement
the initially identified, differentially expressed genes of the LIV/CAD set.
3.1 Sequential Analysis Workflow
3.1.1 DNA Microarrays
The majority of DNA microarrays are classified as oligonucleotide arrays and a cDNA
arrays, according to the type of probes immobilized thereon. Both work on the
principal of base-pairing, allowing probes to hybridize to the targets on the microarray.
The major difference between these two arrays is the fact that cDNA arrays are usually
used to represent a relative measurement of gene expression, whereas oligonucleotide
array results contain absolute values on mRNA concentration. This section provides
an overview of design and techniques of cDNA arrays used for analysis of living and
cadaveric donor kidney biopsies (see section 2.2), as well as of oligonucleotide arrays
which were used for analysis of gene expression in experimental PHN (see section
2.1).
cDNA Arrays Probes used for cDNA arrays are chemically synthesized comple-
mentary DNA (cDNA) strands, containing only fragments of the coding part of the
sequence, complementary to its corresponding mRNA transcript. The total RNA is
first extracted from the experimental samples to be fluorescently labeled in a single
round of reverse transcription. In case of two-color experiments, cy3-dUTP (green)
and cy5-dUTP (red) are preferentially used because they are readily incorporated
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by reverse transcription; they exhibit good photostability and most importantly, are
widely separated in terms of their excitation and emission spectra. The fluorescently
labeled cDNA probes are hybridized to a single array in a competitive hybridiza-
tion reaction. Detection of hybridized probes is achieved by laser excitation of the
individual fluorescent markers, followed by scanning using a confocal scanning laser
microscope. The raw data is represented as a ratio of cy3:cy5 and digitally color
coded such that red represents genes transcriptionally upregulated in the test ver-
sus the reference, green represents genes downregulated and yellow represents those
genes that exhibit no difference between test and reference samples [33]. Besides
the two-color approach, samples can also be hybridized to seperate arrays, resulting
in absolute values mRNA concentration. Popular one-color systems are Affymetrix
GeneChips wich are described in the next paragaph.
Affymetrix GeneChips The Affymetrix GeneChip is one of the most widely used
oligonucleotide array. Whereas cDNA microarrays use long strands of DNA (∼300 nu-
cleotides) as fixed probes, oligo-chips use oligonucleotide sequences (<25 nucleotides)
as their probes. A great part of the genome of an organism can be placed on a sin-
gle microarray as oligonucleotide probes, where each sequence is usually around 25
base pairs in length. These probes are synthesized onto a glass wafer by a combi-
nation of semiconductor-based photolithography and solid phase chemical synthesis
technologies.
One component of each probe, referred to as the perfect match probe (PM) is a
sequence, perfectly complementary to a unique region at the 3 end of the particular
gene. Previous versions of Affymetrix GeneChips were produced with an additional
component, the mismatch probes (MM), which were created by changing the middle
base with the intention to determine the background and nonspecific hybridization
that contributes to the signal for the perfect match oligo. The arrays are scanned
and images are produced and analyzed to obtain an intensity value for each probe.
These intensities represent how much hybridization occurred for each oligonucleotide
probe [34].
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3.1.2 Data Preprocessing
Preprocessing procedures depend on the microarray technology in use. In general,
preprocessing of Affymetrix chips involves 4 steps, summarized in Table 3.1 [35].
Steps Description
Background correction For each array, an estimate of the back-
ground signal, due to unspecific binding
of probes, or chip surface autofluores-
cence, is generated and removed.
Normalization Signal intensities are normalized to
compare data from one chip to another.
PM correction To adjust the perfect match signal in-
tensities. To account for nonspecific
signals, the information derived from
the mismatch signal, is taken.
Expression summary The probe intensities within a given
probe set are combined to a single
value.
Table 3.1: Affymetrix data preprocessing Steps
In the last years, a multitude of normalization methods have evolved. Four of the
commonly used procedures are listed below:
• RMA - Robust Multi-chip Analysis [34]
• MAS5 - Affymetrix Microarray Suite
• VSN - Variance Stabilizing Normalization [36]
• MBEI - Model Based Expression Index [37]
Preprocessing of the raw data derived from the PHN animal model was carried
out in CARMAweb [38] (comprehensive R- and bioconductor-based web service for
microarray data analysis). The application provides different normalization methods,
including those techniques mentioned above, for all current microarray platforms. For
preprocessing of the PHN data, RMA was used and will be described in more detail.
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Background Correction
One characteristic of RMA is to exclusively use PM probes and to ignore MM signals.
The method is based upon the assumption that the observed PM probe signal O con-
sists of a normally distributed background or noise component N and an exponentially
distributed true signal S:
O = N + S, N ∼ N(µ, σ2), S ∼ Exp(α)
where µ is the mean and σ2 is the variance of N and α is the rate of the exponential.
All three parameters are assumed to be equal for all PM probes on a chip and can
therefore be estimated from the data. Eventual negative values for N are truncated
[39].
The corrected intensities are given by
E(s|O = o) = a+ b
φ(a
b
)− φ(o−a
b
)
Φ(a
b
) + Φ(o−a
b
)− 1
where a = o−µ−σ2α and φ and Φ are the standard normal density and distribution
functions, respectively.
Normalization
Due to small differences in RNA quantities and fluctuations generated by the applied
technique, the intensity levels may vary from one replicate to the other due to effects
which are unrelated to the genes, requiring data normalization before they can be
compared. In case of RMA, quantil normalization, described by Bolstad et al. [40]
is used to remove non-biological variability between all arrays.
Goal of this method is to unify the distribution of probe intensities for each array
in a set of arrays. The rational behind is that a quantile - quantile plot shows that
the distribution of two data vectors is the same if the plot is a straight diagonal line.
Usually, the quantiles of two arrays do not lie on the diagonal. To regain the same
distributions the quantiles can be projected to the diagonal of the quantile-quantile
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plot which is equivalent to replacing every component of a quantile vector by the
mean of that vector. Hence, the quantile normalization method is a specific case of
the transformation
x′i = F
−1(G(xi))
where G is estimated by the empirical distribution of each array and F by using
the empirical distribution of the averaged sample quantiles.
PM Correction
As mentioned above, MM intensities are ignored within the RMA framework. For
this reason RMA skips this preprocessing step.
Expression Summary
Typically, each gene on an Affymetrix GeneChip is represented by 16-20 oligonu-
cleotide pairs. The purpose of the summarization step is to establish a single expres-
sion value for each gene on the chip. RMA uses the Median Polish method which is
based on an additive linear model. The following formula indicates that the observed,
background-corrected and quantil-normalized intensity value yij is assumed to be the
summ of the probe affinity effect αi of probe i, plus the real hybridization intensity
µj for array j and the independent, identically distributed error term ǫij with a mean
value of zero [34].
log2(yij) = αi + µj + ǫij
The expression value for the respective probe set is the estimated µˆ for an array
j. This effect is estimated in a robust way by using the median polish algorithm.
The expression values are placed in a matrix where rows represent the probes
and columns the arrays. The fitted matrix is obtained by alternately subtracting the
row and column medians from the matrix elements. Row and column vectors are
updated during each iteration and this process is repeated until the matrix changes
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by less than a small margin or until a pre-defined maximum number of iterations is
reached. This residual matrix is subsequently subtracted from the original, resulting
in a matrix holding the fitted expression values. An estimate for a specific probe
value is obtained by calculating the corresponding row average.
This algorithm provides robust estimates for two reasons. First, using medians
rather than means makes it less sensitive against outliers, and second, estimations
are based on the entire set of arrays.
Preprocessing - cDNA Arrays
Normalization of the cDNA arrays, in this thesis used to derive a gene-expression
profile of the donor kidneys, was done with the microarray image analysis software
integrated in GenePix [41]. The procedure includes background correction and ad-
justment between the red and the green channel.
To reduce the number of redundant genes, and genes with missing values (initially
each of the 32 investigated arrays hold 41121 partially redundant genes), a filter was
applied to every gene in the dataset. Only those genes with values in at least 80% of
the experiments were included in further analysis. Thus, genes with expression levels
similar to the background intensity are eliminated by this step along with basically
unexpressed genes.
The remaining missing values were substituted applying a k-nearest-neighbor al-
gorithm (KNN). The algorithm finds the k genes that are most similar in expression
to the gene with the MV as determined by a distance metric. The missing value is
then estimated as the average of these k neighbor genes for the same array, weighted
according to the inverse of their distance [42]. In case of the donor kidney experiment
k was set to 10.
Comparison of two microarray datasets usually leads to systematic biases arising
from variability in experimental conditions. To prevent an erroneous detection of
differences in the gene expression pattern, several methods have been developed,
including singular value decomposition (SVD), which was used to correct biases in
the donor kidney experiment. SVD is a linear transformation of the expression data
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from the genes × arrays space to the reduced eigengenes × eigenarrays space. In
this space the data are diagonalized, such that each eigengene is expressed only in
the corresponding eigenarray, with the corresponding eigenexpression level indicating
their relative significance. The eigengenes and eigenarrays are unique, and therefore
also data-driven, orthonormal superpositions of the genes and arrays, respectively
[43].
3.1.3 Clustering
The idea of the clustering step is to group similar data objects and discover patterns
in a given pool of data. Objects are grouped based on their proximity to each other
via a distance metric. In case of the analysis of the donor kidney experiment, the
correlation distance
d(X, Y ) = 1− rXY
was used, where rXY is the Pearson correlation coefficient between two vectors X
and Y, and
d(X, Y ) = 1−
∑n
i=1(Xi − X¯)(Yi − Y¯ )√∑n
i=1(Xi − X¯)
2
√∑n
i=1(Yi − Y¯ )
2
where n is the length of the vectors and X¯ and Y¯ are their mean values. Since
the Pearson correlation coefficient rXY takes values between -1 and 1, the distance
1−rXY will vary between 0 and 2. The Pearson correlation finds whether two objects
vary in the same way. The correlation will be high if the corresponding expression
levels increase or decrease at the same time, otherwise the correlation will be low.
Once the distances between all objects are calculated, a linkage rule, determining
the inter-cluster distances, has to be defined. In general, there are three possibilities:
Single linkage calculates the distance between clusters as the distance between the
nearest neighbors by measuring the distance between each member of one cluster
to each member of the other cluster and taking the minimum of these.
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Average linkage measures the average distance between each member of one cluster
to each member of the other cluster.
Complete linkage defines the distance between the furthest neighbors by taking
the maximum of distance measures between each member of one cluster to each
member of the other cluster.
For further analysis a hierarchical cluster algorithm within Statistica 6 (Statsoft
Inc., Tulsa, OK, USA), using the complete linkage rule, was computed. Figure 3.1
gives a graphical representation of the algorithms function.
Figure 3.1: The basic agglomerative clustering steps.
The applied steps are:
1. Calculate the correlation distance between all data points.
2. Cluster the data points to the initial clusters, each consisting of one element.
3. Calculate the inter-clusters distances.
4. Repeatedly cluster most similar clusters into a higher level cluster with respect
to step 3.
5. Repeat steps 3 and 4 for the most high-level clusters.
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Besides this agglomerative (bottom up) procedure, clusters can also be build di-
visive (top down), starting with a super-cluster containing all elements, followed by
splitting iteratively into sub-classes.
3.1.4 Statistical Analysis
The next step is to discover and identify genes that are differentially expressed be-
tween the groups of samples, as in the PHN experiment, between healthy and diseased
rats. Such microarray experiments generate large multiplicity problems in which
thousands of hypotheses have to be tested simultaneously. For every single gene the
following decision has to be made:
1. the observed gene is over/under expressed in comparison to the healthy group
2. the gene is not differentially expressed in comparison to the healthy group
For the decision a t-test, assuming unequal sample sizes and unequal variance, is
calculated according to the equation below:
t =
X − Y√
(σx)2
nx
+
(σy)2
ny
where X refers to group1, Y to group2, σ to the corresponding standard deviation,
and n to the size of the sample.
The test results in either rejecting the null hypothesis H0 which is equivalent to
case 1 or accepting H0 which is the same as described in case 2. The latter could also
be described as rejecting the alternative hypothesis HA.
A statistical decision process usually comes along with possible errors. The two
sources of error are listed below:
type I error: the error of rejecting a hypothesis that should have been accepted (⇒
false positive)
type II error: the error of accepting a hypothesis that should have been rejected
(⇒ false negative)
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When multiple hypotheses are tested, as in case of microarray analysis, the proba-
bility that a type I error is committed increases sharply with the number of hypothe-
ses. There are some standard type I error rates [44]:
FWER - Family Wise Error Rate: The FWER is defined as the probability that
the analysis yields any false positive findings.
FWER = Pr(V ≥ 1)
where V is the number of false positives.
PFER - Per Family Error Rate: The PFER measures the expected count E of
false positives.
PFER = E(V )
FDR - False Discovery Rate: The FDR can be interpreted as the expected pro-
portion Q of significant findings that are indeed false positives.
FDR = E(Q)
PCER - Per-Comparison Error Rate: The PCER is defined as the ratio of the
expected false positives to the number of hypothesis G.
PCER =
E(V )
G
maxT Multiple Testing
Statistical significance of genes separating arrays of the donor kidney biopsies in dis-
tinct clusters was performed by calculating p-values, which were corrected for multiple
testing using a maxT step-down procedure [45] with the aim to control the FWER.
In step-down procedures, the hypotheses corresponding to the most significant test
statistics are considered successively, with further tests depending on the outcomes
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of earlier ones. As soon as one hypothesis is accepted, all remaining hypotheses are
accepted.
The algorithm estimates the joint distribution of the test statistics t1, ..., tm, where
m is the number of tested hypothesis, under the complete null hypothesis H0 by
permuting the samples. For the bth permutation, b = 1, . . . , B
1. Permute the n columns of the data matrix X.
2. Compute the test statistics t1,b, . . . , tm,b for each hypothesis
3. Next, compute successive maxima of the test statistics
um,b = |trm , b|
uj,b = max
(
uj+1,b, |trj , b|
)
for j = m− 1, . . . , 1,
where rj are such that |tr1| ≥ |tr1| ≥ . . . ≥ |trm | for the original data.
The adjusted p-values are estimated by
p˜r1 =
∑B
b=1 I
(
uj,b ≥ |trj |
)
B
with the monotonicity constraints enforced by setting
p˜r1 ← p˜r1 , p˜r1 ← max
(
p˜r1 , p˜r1−1
)
for j = 2, . . . ,m.
SAM - Significance Analysis of Microarrays
Tusher et al. [46] developed a method, Significance Analysis of Microarrays (SAM),
addressing the FDR. On the basis of t-tests, it assigns a score to each gene accord-
ing to the change in gene expression relative to the standard deviation of repeated
measurements. For genes with scores greater than an adjustable threshold, SAM
uses permutations of the repeated measurements to estimate the percentage of genes
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identified by chance. This method was applied in the course of analyzing the PHN
rat model.
Since the signal-to-noise ratio is decreasing with decreasing gene expression and
the fluctuations are gene specific, SAM defines the relative difference d(i) in gene
expression as follows:
d(i) =
X¯I(i)− X¯U (i)
s(i) + s0
where X¯I(i) and X¯U (i) are defined as the average levels of expression for gene i
in states I and U (in our case healthy and diseased), respectively. The gene-specific
scatter s(i) is the standard deviation of repeated expression measurements:
s(i) =
√√√√a
{∑
m
[Xm(i)− X¯U (i)]
2 +
∑
n
[Xn(i)− X¯I(i)]
2
}
where
∑
m and
∑
n are sums of the expression values in states I and U, respec-
tively, a =
( 1n1
+ 1n2
)
(n1+n2−2)
, and n1 and n2 are the numbers of measurements in states I
and U.
For each balanced permutation, relative differences dp(i) are calculated. The
expected relative difference, dE(i), is defined as the average over all permutations,
dE(i) =
∑
p
dp(i)
n .
3.1.5 Functional Analysis
The next step was to discover and interpret the biological function of the genes deemed
to be of interest following the analysis of the microarray experiment. Different tools
and databases exist that facilitate and fasten the information search.
The GO project[47] has developed three structured, controlled vocabularies (on-
tologies) that describe gene products in terms of their associated biological processes,
cellular components and molecular functions in a species-independent manner. The
terms are structured as an acyclic directed graph, providing a hierarchial functional
annotation of genes.
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Another ontology, used for analysis of differentially expressed genes, is similar
in structure: the protein analysis through evolutionary relationships (PANTHER)
classification system [6]. Using this tool, enriched and depleted functional categories
were identified using the PANTHER data set covering the whole rat genome of interest
as reference dataset. The ratio of expected to observed frequencies of genes assigned
to certain ontology categories were compared using the χ2 test to derive significance
of differences.
Next to gene ontologies, pathway databases like KEGG (Kyoto Encyclopedia of
Genes and Genomes) [7], holding information on metabolic networks and signaling
transduction cascades, were searched.
Besides the manual search in the described databases, the statistically significant
genes in the donor kidneys were further characterized using GenMAPP [48] and High-
density Array Pattern Interpreter (HAPI) [49]. GenMAPP is a computer application
designed to visualize gene expression data on maps representing biological pathways
and groupings of genes. HAPI provides a data mining method that uses keywords
from the published literature linked to specific genes to present a view of the similarity
of genes within a group of interest.
3.1.6 Network Analysis
Grouping genes with similar functions or genes interacting is usually the next step
in interpreting the data. Starting with the set of differentially expressed genes in the
PHN model, a protein-protein interaction network following the nearest neighbour
expansion method [50] was generated, using data from the Online Predicted Human
Interaction Database (OPHID) [10] on interactions of rat proteins.
To identify possible molecular complexes the graph theoretical clustering algo-
rithm MCODE (Molecular Complex Detection) [51] was applied. It operates in
three stages, vertex weighting, complex prediction and optionally post-processing to
filter or add proteins in the resulting complexes by certain connectivity criteria.
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Vertex weighting is based on the local network density. The weight given to a
vertex i is the product of the vertex core-clustering coefficient Ci and the highest
k-core level kmax of the immediate neighborhood of the vertex. A k-core is a graph
of minimal degree k, hence kmax is the central most densely connected subgraph.
Differing from the definition of the clustering coefficient Ci
Ci =
2n
ki(ki − 1)
where ki is the vertex size of the neighborhood of vertex i, excluding i itself, and
n is the number of edges in the neighborhood, the core-clustering coefficient includes
the vertex i. This results in amplifying the weighting of heavily interconnected graph
regions while removing the many less connected vertices that are usually part of a
biomolecular interaction network, known to be scale-free.
Complex prediction takes as input the vertex weighted graph. Given a specified
vertex weight percentage (VWP), the algorithm seeds a complex with the highest
weighted vertex and recursively moves outward including vertices in the complex
whose weight is above the given threshold. This way, the most dense regions of the
network can be identified.
This sequential workflow rests on transcripts and proteins which show statistically
significant differences in expression levels when compared to a control sample. How-
ever, measured differences in mRNA abundance do not necessarily correlate with
biological relevance. The following section describes an integrated workflow which
is aimed at the expansion of an existing core set of differentially expressed genes in
renal transplants on the basis of a dependency graph.
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3.2 Integrated Analysis Workflow
The following section describes an analysis workflow, based on the concept of a depen-
dency graph. In contrast to the previously outlined sequential analysis, this approach
integrates data on genes, RNA and proteins to objects and augment them with in-
formation, derived from different levels of observation. Represented as nodes, these
objects are linked by edges which are weighted according to estimated functional
dependencies.
3.2.1 Object Annotation
The annotation of the molecular objects in the dependency graph integrates given
data from different sources. Object definition includes a genes functional annotation,
its reference gene expression profile determined for 32 tissues, the interaction data of
encoded proteins, and a consensus on each proteins subcellular location. Table 3.2
summarizes the data sources, used for object annotation. A detailed description of
the different contributions is given in the following paragraphs.
Data Source Level of Observation Data Family
OPHID
KEGG
interactome INT
PANTHER
IntAct
GSE7905 transcriptome DGE
KEGG
GO phenome SEM
PANTHER
WPSORT
SWISSPROT localisome LOC
Omenn et al.
Table 3.2: Data Sources
Functional Interaction (INT) The Functional Interactions data family consti-
tutes on the basis of four different data sources: The OPHID database, the IntAct
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database [52] and parsed interactions from the KEGG- [7] and PANTHER [6] path-
ways.
The annotated interactions in OPHID (The Online Predicted Human Interaction
Database) are mainly collected from BIND [11], HPRD [12, 13], MIPS [14], DIP [53],
and MINT database [15], while another part of interactions are derived by mapping
high-throughput model organism data from S. cerevisiae, C. elegans, D. melanogaster,
and M. musculus to human proteins. Furthermore OPHID contains PPI predictions
based upon gene co-expression in expression profiles from GeneAtlas [54], domain
co-occurrence and similarity measures in GO.
The data available in the IntAct database originate entirely from published lit-
erature and is manually annotated by expert biologists. IntAct was built by the
EBI-EMBL (European Bioinformatics Institute of the European Molecular Biology
Laboratory) and made publicly available using the PSI-MI (Proteomics Standards
Initiative Molecular Interaction format) XML Standard [55].
KEGG (Kyoto Encyclopedia of Genes and Genomes) and PANTHER (Protein
ANalysis THrough Evolutionary Relationships) are databases consisting of pathways
which can be used for extracting PPIs. The KEGG database contains a collection of
manually drawn molecular pathway maps, each map representing KEGG’s knowledge
on the molecular interaction and reaction networks for metabolism, genetic informa-
tion processing, environmental information processing, cellular processes and human
diseases, whereas PANTHER primarily describes signaling pathways.
The overall number of functional protein-protein interactions derived from
OPHID, IntAct, KEGG and PANTHER resulted in 86012 unique interactions which
were further augmented with information from data families as described in the fol-
lowing paragraphs.
Gene Expression Patterns (DGE) According to a public domain GEO dataset
GSE7905 [56], holding normalized gene expression profiles of 32 human tissues, vectors
with tissue specific expression levels could be assigned to 15382 molecular objects.
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Semantic Annotation (SEM) The semantic annotation terms were collected
from the Gene Ontology (GO) [47], KEGG and PANTHER databases.
Semantic annotation terms from KEGG and PANTHER pathways were extracted
through parsing each pathway for the underlying set of genes. Each pathway’s name
can be considered to be a semantic annotation for the genes contained in this pathway.
Because of the hierarchial nature of the GO annotation as described in the previous
section, different annotation terms are more or less specific resulting in the fact that
different GO annotation terms span from annotating very few up to some thousand
genes. Hence, a normalization step was implemented to make terms from the three
different sources comparable. Finally, 586 unique semantic annotation terms were
integrated in the object annotation.
Subcellular Location (LOC) To enrich the molecular entities with information
about the subcellular location for each underlying protein, the prediction algorithm
WPSORT (WoLF PSORT) [57] was used and combined with experimentally available
subcellular location information as given in the SWISSPROT subcellular location
comment block [3], and the plasma proteome as reported by Omenn et al [58].
WPSORT is an extension of the PSORT II program for protein subcellular loca-
tion prediction. It converts protein amino acid sequences into numerical localization
features, based on sorting signals, amino acid composition and functional motifs such
as DNA-binding motifs. The algorithm results in a numeric vector of length ten where
each numeric value represents the occurrence probability in the following classes of or-
ganelles in percent: cytosol, cytoskeleton, endoplasmic reticulum, extracellular, golgi
body, lysosome, mitochondria, nuclear, peroxisome, plasma membrane.
The SWISSPROT protein knowledgebase connects amino acid sequences with
an overview of relevant information, including experimental results and computed
features.
For refinement and correction, the experimentally validated data from SWIS-
SPROT and Omenn et al. were normalized to the WPSORT format. To give consid-
eration to the more accurate information derived from experiments, the corresponding
vector entries (vSWI ,vO) were exclusively set to 0% and 100%.
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Data integration followed the principle:
vLOCi =
vWPSORTi + vSWIi + vOi∑10
i=1 vWPSORTi + vSWIi + vOi
where vWPSORTi , vSWIi and vOi denote the localization probabilities and i de-
notes the position in the numeric vectors for the respective organelle. The sum of
each position in the numeric vectors is divided by the sum of all vectors probability
results in vLOCi . Thus, 18138 molecular objects could be annotated by the means of
their proteins subcellular location.
It has to be mentioned that the described annotation of graph objects does not
consider the different splice variant products which can differ substantially in function.
A future goal is to overcome this shortcomings but this issue is nontrivial since that
the number of splice products is enormous.
3.2.2 Graph Construction
For construction of the dependency graph only those 18572 objects were considered,
showing to have a corresponding identifier to their NCBI Gene Symbol in the NCBI
Reference Sequence collection (RefSeq) [5]. Each object consists of 4 data entries
oINT , oDEG, oSEM , oLOC , corresponding to the data families described in the pre-
vious section.
The data entries were realized as vectors, like for an entry oiINT , the corresponding
string vector consists of all objects oj , where 1 ≤ j ≤ 18575 and i 6= j, having an
interaction with oi. The oiDEG entry is a numeric vector where each coordinate in
the vector represents a quantile normalized signal to noise expression value for 32
human tissues. Annotation terms, according to an entry oiSEM , are represented as
coordinates of a string vector and the oiLOC entry is a probability vector, containing
probabilities for the occurrence of oi in each of the 10 subcellular locations as listed
in the previous section.
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Dependency Matrix
The pairwise distances dij between any two objects oi and oj were stored in a depen-
dency matrix D. Definitions for the 4 contributions to dij are given below:
• fINTij is a binary function:
fINTij =
{
1 if oiINT
⋂
ojINT 6= {∅},
0 if oiINT
⋂
ojINT = {∅},
• fDEGij is the Pearson coefficient of correlation between two objects oiINT and
ojINT , µi and µj their expected values and σi and σj their standard deviations:
fDEGij =
[(oiDEG − µi)(ojDEG − µj)]
σiσj
• fSEMij calculates the Dice coefficient (taken as a string similarity measure)
between two objects:
fSEMij =
2|oiSEM
⋂
ojSEM |
|oiSEM |+ |ojSEM |
• fLOCij is defined as the difference between the probability vectors oiLOC and
ojLOC :
fLOCij = 1−
10∑
x=1
|oiLOC − ojLOC |
To obtain a pairwise dependency score, the following function was computed for each
entry dij in D:
dij = fINTij + 2
fDEGij + fSEMij + fLOCij
3
Following this function, object dependencies are biased for physical or logic protein
interactions (contributing with an dependency score of +1), whereas the other three
contributions are equally weighted with a total contribution in the interval [-1,1]. The
overall dependency score dij consequently scales in the interval [-1,2].
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Graph Characteristics
The previously described matrix represents a weighted functional dependency network
in form of an undirected complete graph where each entry describes an edge weight
in the network. An excerpt of this reference network is shown in Figure 3.2.
Figure 3.2: Visualization of an excerpt of the dependency graph. Nodes represent
objects; only nodes with at least one edge with a weight > 1.0 are shown. At this
particular cutoff one main sub-graph is found, complemented by various small sub-
graphs. The graph view was generated by Cytoscape using the organic layout option
[59, 60].
The cutoff for edge weights can be varied in discrete steps, thus enabling the anal-
ysis of subnetworks, only including edges, having a higher weight than the introduced
cutoff. Figure 3.3 shows characteristics of this reference network, namely number of
edges, number of vertices, number of subgraphs, as well as the Index of Aggregation,
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depending on the cutoff.
Figure 3.3: Graph characteristics were calculated for defined cutoffs, ranging from
0.5 to 2 for the complete graph (G) as well as for the largest subgraph (maxGs). (A)
Shows the number of edges, (B) the number of vertices, (C) the number of subgraphs
and (D) the Index of Aggregation.
The Index of Aggregation (IoA) defines the ratio of the total number of vertices
in a subgraph to the total number of all given vertices in the graph [61].
In contrast to a sequential analysis this integrated procedure allows the comple-
mentation of a core set by genes that were initially considered as insignificant in a
statistical sense. However, not only differences in transcript abundance have impact
on cellular processes. This dependency graph approach was applied on the LIV/CAD
dataset, aimed to identify functionally relevant objects and subgraphs.
RESULTS AND DISCUSSION
The following sections provide results derived by applying the sequential analysis
workflow in context of the animal model of PHN, and the dependency graph approach
applied on the LIV/CAD dataset. Finally the results are discussed.
4.1 PHN Dataset
4.1.1 Results
The preprocessed raw data, comprising information of 20 arrays, each holding ex-
pression values of 15924 transcripts, was further analyzed to identify differentially
regulated genes in healthy and diseased rats.
Clustering
After preprocessing, the 20 arrays underwent a hierarchical clustering step, resulting
in the pattern represented as a dendrogram in figure 4.1.
As shown in figure 4.1 the control and the diseased group form almost two separate
clusters, with the exception of samples 1Pd3, 7Pd3 and 10Cd3 and 5Pd3 respectively.
The latter two cluster separately. Furthermore, arrays of the d3 group cluster together
very closely, indicating that the expression patterns are similar, and the same can be
observed within group d6. This is due to the fact that the development of subepithelial
immune deposits in the glomerular capillary walls and proteinuria in PHN commences
5 to 7 days after injection of the antibody.
Statistical Analysis
The preprocessed data were statistically analyzed using two different methods, namely
maxT adjustment and SAM analysis. A description of the results and a comparison
of the methods is given in the next sections.
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Figure 4.1: The dendrogram shows the clustering results for gene expression profiles
in glomeruli of healthy and Fx1A induced rats (C and P respectively), 3 as well as 6
days (3d and 6d respectively) after injection.
maxT Adjustment By setting the overall p-value to 0.05 (indicating that at least
5% of the observed differences in expression between genes of the diseased and the
control group occured by chance), the t-test adjusted by the maxT method revealed
33 unique genes in case of group d3 and 186 unique genes in case of group d6, which
were differentially regulated in the control and the diseased glomeruli probes.
SAM Analysis SAM analysis was performed setting the false discovery rate to
<5%, resulting in 108 and 580 unique differentially expressed genes in group d3 and
d6 respectively. Figure 4.2(a) and figure 4.2(b) show the scatter plots of the observed
relative difference d(i) vs. the expected relative difference dE(i) for the two time
points.
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All genes but one revealed by the t-test with maxT adjustment were also found in
the data set resulting from SAM analysis. This is true for both groups d3 and d6,
except the one before mentioned gene which is missing in the SAM data set for d3.
The focus of further analysis steps was on the genes identified as significant after
SAM analysis. Genes showing a fold change <1.5 were not cosidered as significantly
differentially expressed and were filtered out, resulting in two final sets, holding 54
genes in case of group d3 and 226 genes in case of group d6. All but 9 genes upregu-
lated three days after injection of Fx1A were also expressed significantly differential
six days after treatment. Altogether, 235 unique genes (PHN core set), all of them
being upregulated in diseased rats, could be identified as differentially expressed when
comparing control and immunized rats.
Functional Analysis
The 235 differentially regulated genes were categorized according to the biological
process (GO term) they are involved in, as listed in tables 4.1 - 4.8. This catego-
rization is not exclusive since some of the identified genes play roles in more than one
process.
As can be seen in tables 4.1 and 4.2, a multitude of differentially regulated genes
encode structural proteins of the cytoskeleton or proteins involved in cell adhesion,
including integrin beta 1 (Itgb1), secreted phosphoprotein 1 (SPP1), lamin A (Lmna),
desmin (Des), nestin (Nes), or tubulin beta 2 (Tubb2). Another strongly represented
process is cell cycle. This category holds several genes encoding prominent proteins
like the transforming growth factors beta 2 and 3 (Tgfb2, Tgfb3), the two cyclins B1
and B2 (Ccnb1, Ccnb2), or the proliferating cell nuclear antigen (Pcna).
The mentioned categories not only show an absolute enrichment of identified genes
but are also significantly overrepresented in at least one time point in comparison to
the PANTHER reference data set of the whole rat genome. All over/underrepresented
processes are listed in table 4.9. Figure 4.3(a) and 4.3(b) respectively demonstrate
the number of genes assigned to a certain category compared to all genes categorized
to an overrepresented process.
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(a) 3 days after immunization
(b) 6 days after immunization
Figure 4.2: Scatterplot of the SAM analysis : The two dotted lines represent the
region within +/- delta units (set to 1.8) from the observed = expected line. The
genes whose plot values are represented by black dots are considered non-significant,
those colored red are significantly upregulated, and the green ones are significantly
downregulated.
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(a) 3 days after immunization
(b) 6 days after immunization
Figure 4.3: Biological processes that are significantly enriched by genes of the PHN
core set.
48
The overrepresented functional groups before onset of proteinuria (d3) diverge
from those after proteinuria has commenced (d6). The relative amount of cell cycle
associated genes is 21.3% of all differentially regulated genes after the onset of pro-
teinuria compared to 5.6% before. An even larger change was found for the genes
with a function in cellular immunity and defense. They are not enriched (3.7%) at
day 3, but at day 6 they make up 16.7% of all abundant genes.
A total of 30 genes in case of the dataset of identified genes in group d3 and
82 genes in group d6 could be assigned to KEGG pathways. An overview of these
pathways and number of involved genes is given in table 4.10 .
Day 3 Day 6
Pathways Number of Genes Number of Genes
Focal adhesion 6 9
Cell cycle 1 9
Regulation of actin cytoskeleton 3 8
MAPK signaling pathway 3 7
Cell communication 2 7
Leukocyte transendothelial migration 3 5
Gap junction 2 5
axon guidance 0 5
Tight junction 3 4
Adherens junction 2 4
p53 signaling pathway 0 4
Adipocytokine signaling pathway 2 3
ECM-receptor interaction 1 3
TGF-beta signaling pathway 1 3
Cytokine-cytokine receptor interaction 1 2
Cell adhesion molecules 0 2
Toll-like receptor signaling pathway 0 2
Table 4.10: KEGG pathways and the number of genes according to each category.
Network Analysis
To detect coherences between genes of the PHN core set and physical interaction
partners, initially not identified as differentially regulated, a protein network analysis
49
was performed. Based on information derived from the Online Predicted Human In-
teraction Database (OPHID), protein-protein interactions were visualized using the
Cytoscape bioinformatic platform for visualizing molecular interaction networks. The
network includes the genes of the PHN core set and their interaction partners, having
at least 2 edges. To detect densely connected regions, the graph theoretic cluster-
ing algorithm ”Molecular Complex Detection” (MCODE) was used. Running the
algorithm with a k-Core of 2 and a maximal Depth of 100 resulted in detection of 4
clusters shown in figure 4.4.
Components of each of the 4 clusters can be assigned to a certain biological process.
All genes in cluster1 play a role in cell cycle. Except of Lgals, genes in cluster2 are
associated with cell adhesion. Cluster3 completely represents growth factors and most
of the genes in cluster4 are involved in structure and motility.
4.1.2 Discussion
Passive Heyman nephritis (PHN) is a rat model of immune complex glomerular dis-
ease that closely resembles human membranous glomerulonephritis. PHN is induced
by an injection of anti-Fx1A antibodies which are raised against rat proximal tubular
brush-border antigens. Binding of the antibodies leads to activation of the comple-
ment cascade and insertion of the C5b-9 membrane attack complex into the glomeru-
lar basement membrane, accompanied by podocyte effacement and a conspicuous
lack of inflammatory cells [20]. Within 5 to 7 days after injection, abnormal protein-
uria occurs. These findings are consistent with the results of the clustering analysis,
showing almost two separate clusters for arrays holding probes 3 and 6 days after
immunization, respectively.
The statistical analysis procedure resulted in 235 significantly upregulated genes.
Notably significant is the gene Tagln, also known as SM22, which shows a fold change
of 69.77 at day 3 and 38.66 6 days after induction of PHN. The protein encoded by
Tagln is transgelin, a cytoskeletal protein that is exclusively expressed in smooth mus-
cle cells. It has been shown previously that Tagln is one of the genes highly expressed
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(a) Cluster1 (b) Cluster2 (c) Cluster3
(d) Cluster4
Figure 4.4: Clusters detected by MCODE. Node colors indicate the measured fold
change, green for under-expressed and red for over-expressed genes (orange <1,5,
red >1,5, dark red >2) in rats with induced PHN when compared to healthy rats.
Hexagons represent those genes that were considered to be significantly upregulated
in previous analysis.
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in kidneys with anti-glomerular basement membrane nephritis (caused by antibody
response against antigens in the glomerular basement membrane), providing an indi-
cation that injured glomerular epithelial cells undergo structural alterations [62].
Furthermore, Tagln has been identified as a repressor of the matrix metallopro-
teinase MMP-9, a member of a family of neutral proteinases that can degrade extra-
cellular matrix components [63]. MMP-9 is produced by podocytes, which therefore
are able to enzymatically modify the glomerular basement membrane they adhere to.
The high expression of Tagln could indicate the activation of an cellular emergency
program, trying to prevent cell damage caused by MMP-9. Two further genes, iden-
tified to be upregulated in PHN, encode well known inhibitors of several members
of the MMP family, namely the tissue inhibitors of metalloproteinases Timp1 and
Timp2.
The dense cluster4 4.4(d), identified by network analysis, also reflects the struc-
tural changes and cytoskeletal rearrangements of the glomerulus as a result of the
experimental injury. One of the interacting proteins is vimentin, a class-III interme-
diate filament of the cytoskeleton and usually found in mesenchymal tissues. The
strong upregulation after the onset of proteinuria (d6) might suggest a phenotypic
transformation of parts of the glomerulus tissue to a mesenchymal morphology as can
be observed during diverse chronic kidney diseases [64].
Another gene in cluster4 is Myh9, which encodes for the nonmuscle myosin heavy
chain protein myosin-IIA, a part of the actinomyosin complex. Previous studies
demonstrated that myosin-IIA is involved in changes of cell morphology in many
cell types [65].
The great number of differentially expressed genes in PHN induced rats, involved
in cell structure and motility (Figure 4.3), suggest the critical relevance of an intact
cytoskeleton.
Proteinuria emerges from a loss of the permeability barrier in the kidney. For an in-
tact barrier, podocyte-podocyte as well as podocyte-glomerular basement membrane
junctions are essential but usually damaged by changes in the extracellular matrix in
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case of many nephropathies. Fibronectin1 (Fn1) for example is involved in mecha-
nisms like cell adhesion and fibrosis and it was shown that its expression is induced by
high-glucose in human renal cells [66], suggesting similarity between the PHN model
and development of diabetic nephropathy. The gene is not differentially expressed in
the PHN dataset but is part of cluster3 4.4(c).
One further interacting protein in cluster3 is osteopontin. The encoding gene is
Spp1 which is upregulated before the onset of proteinuria. Osteopontin is expressed
in distal tubular cells of the kidney and it is jointly responsible for urinary stone
formation [67]. Furthermore, it has been shown that upregulation of osteospotin in
the kidney influences monocyte migration into renal compartments and aggravates
the immune response after the initial injury [68].
Another phenomenon in experimental membranous nephropathy is that C5-b9 in-
duced injury to podocytes comes along with DNA synthesis but not cytokinesis.
Previous studies demonstrated the role of the transforming growth factor Tgfb1 to
limit DNA synthesis in renal cells. The PHN core set does not involve Tgfb1 but the
isoforms Tgfb2 and Tgfb3, a fact that also seems to be indicated by Shankland et
al. [69]. This leads to the assumption that Tgfb2 and Tgfb3 have different biological
effects than Tgfb1 and might inhibit the proliferation of injured podocytes. The in-
teraction network between Tgfb isoforms and their receptors represented as cluster1
in figure 4.4(a) additionally demonstrates their coherence with podocyte injury.
As indicated by the high expression levels of cyclins B1 and B2 (Ccnb1,Ccnb2)
and the cell division cycle 2 homolog Cdc2a, all involved in the M-phase of cell cycle,
podocytes have the ability to increase cell cycle proteins required for mitosis. The
lack of proliferation might be due to a regulatory disturbance in cytokinesis [70].
Cell cycle arrest can be the consequence of upregulated Gadd45 (growth arrest
and DNA damage inducible 45) which was shown to be expressed after sublytic injury
activated by C5b-9 [71], suggesting that DNA damage occurs in the course of injury.
The isoforms Gadd45a and Gadd45g, besides Ccnb2, Cdc2a and the proliferating cell
nuclear antigen Pcna, are part of cluster2 4.4(b). Pcna also plays an important role
in DNA repair and influences cell survival. The upregulation of Pcna 6 days after
53
immunization of the rats may be due to an activation of repair processes in the injured
tissue [72].
The results of the sequential analysis of the PHN dataset clearly demonstrate the
crucial role of an intact permeability barrier in the kidney, strongly associated with
glomerulus and podocyte interaction. The main important involved biological pro-
cesses are cell structure and motility, cell adhesion, cell cycle and immunity. Failure in
podocyte structure or proliferation as a consequence of complement mediated injury
is critical and may lead to further damage of the glomerulus and proteinuria.
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4.2 LIV/CAD Dataset
The following section describes results and discusses usage of the dependency graph
approach applied on 105 genes (LIV/CAD core set) initially identified as differentially
regulated between living and cadaveric donor kidneys, as identified by a genome-wide
expression analysis of 32 kidney biopsies [32].
4.2.1 Results
Out of 132 statistically significantly up- or downregulated transcripts, 105 could
be functionally annotated and assigned to PANTHER biological processes. In
particular, they belong to the functional categories proteolysis, immunity and
defense/complement-mediated immunity and metabolism. Results derived from Gen-
MAPP, MAPPFinder and HAPI emphasize the complement system as a critical part
in differentiation between living and cadaveric donor kidneys. The most frequently
found MeSH term was ”Complement” and the only identified pathway by GenMAPP
and MAPPFinder was again the complement system.
Among the 105 genes of the LIV/CAD core set, 96 could be mapped on our de-
pendency graph. For interpreting the differentially regulated genes on the level of the
graph we calculated those subgraphs showing edge weights ≥1.3 and holding at least
one member of the core set. The resulting subgraphs consist of a total of 166 nodes,
including 17 members (see Figure 4.5).
Although the number of differentially regulated genes found in the dependency
graph when using an edge weight cutoff of 1.3 is rare, a further enrichment of genes
according to initially overrepresented biological processes can be observed. 61 of the
identified dependency graph objects are involved in immunity and defense while this
group is represented by 18 in case of the set of 105 differentially expressed genes. A
similar outcome can be found for the category proteolysis. In contrast, complement-
mediated immunity lost significance. Table 4.11 gives an overview of the overrepre-
sented processes.
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Figure 4.5: The figure shows subgraphs identified by introducing an edge weight
cutoff of 1.3. Each subgraph holds at least one gene of the 105 differentially regulated
genes found when comparing living and cadaveric donor kidneys on the level of gene
expression (shown in red).
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Statistical Analysis Dependency Graph Analysis
Biological process p-value Biological Process p-value
Immunity and defense 1.33E-04 Immunity and defense 5.41E-34
Lipid metabolism 3.76E-04 Cytokine and chemokine
mediated signaling pathway
5.68E-29
Proteolysis 8.96E-04 Signal transduction 1.76E-27
Coenzyme metabolism 2.31E-03 Blood Clotting 4.81E-27
Vitamin/cofactor transport 6.49E-03 Cell communication 5.42E-25
Amino acid metabolism 1.03E-02 Cell adhesion 2.88E-24
Complement-mediated Im-
munity
1.17E-02 Proteolysis 6.72E-20
Table 4.11: PANTHER biological processes and their significance of population ex-
pressed as p-value for statistical analysis of the LIV/CAD gene expression data and
analysis in the context of the dependency graph.
In terms of the number of differentially regulated genes the resulting subgraphs
are rather sparse. For further analysis the weighted shortest paths (Dijkstra algo-
rithm [73]) between all pairs of the core set, showing at least one edge with a weight
exceeding 1.0, were computed. Figure 4.6 displays the graph component, holding 32
genes of the LIV/CAD core set and 230 additional nodes that build the links between
the members of the core set. Out of these 230 genes, 25.7% (59 genes) are involved in
immunity and defense. Table 4.12 lists the main overrepresented biological processes
resulting from the shortest path analysis.
4.2.2 Discussion
Kidneys from living donors hardly ever exhibit acute renal failure and display longer
allograft survival compared to cadaveric organs [21]. Clinical observations have shown
alterations in brain-dead donor organs that can cause organ injury, which has been
suggested to alter the immunological or inflammatory status of the organ after trans-
plantation [74]. The main findings of the sequential, statistical analysis workflow
were increased activations of immunity and defense mechanisms in cadaveric donor
kidneys compared to living transplants [32].
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Figure 4.6: The figure displays the graph component consisting of the shortest paths
between 32 members of the LIV/CAD core set. Red nodes represent members and
green nodes additional genes associated with immunity and defense. The detailed
graph area shows objects associated with complement-mediated immunity.
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Shortest Paths Analysis
Biological process p-value
Immunity and defense 1.94E-35
Signal transduction 2.95E-32
Cell proliferation and differ-
entiation
3.18E-32
Intracellular signaling cas-
cade
6.04E-22
Developmental processes 4.39E-21
Protein phosphorylation 1.15E-20
Cell cycle control 2.62E-18
Table 4.12: Overrepresented PANTHER biological processes for genes identified by
shortest path analysis of the LIV/CAD gene expression data.
The aim of the dependency graph approach was to identify additional and relevant
genes previously not considered by statistical analysis but linked to members of this
core set. Following the construction principle of the dependency graph, interlink-
ing paths may indicate functional dependencies between objects. Indeed, a further
enrichment of genes involved in corresponding biological processes could be identified.
Previous studies have implicated complement activation in the pathogenesis of Is-
chemia reperfusion injury (I/R) in the kidney which is a common cause of acute renal
failure and impacts short- as well as long-term graft survival after kidney transplan-
tation [75]. The subgraph, consisting of the shortest paths between 32 members of
the LIV/CAD core set, includes 10 components of the complement system. Early
components of the complement cascade namely C1r, C1s, C2, and factor B (CFB)
are upregulated in cadaveric donor kidneys. C3, C5, C7, the complement factor H
(CFH), the decay accelerating factor for complement CD55 and the mannan-binding
lectin serine peptidase MASP1 could be found by the shortest path approach.
For example, shortest paths between CFB and any of the remaining 31 LIV/CAD
core set members in the graph include C3, indicating a strong dependency of the two
objects. A similar network topology led to the detection of C5 as a relevant gene in
context of the core set of differentially expressed genes (see figure 4.6). In a model of
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renal I/R injury by Zhou et al. [76], C3 and C5 deficient mice were protected from
renal failure. Furthermore, this study showed that mice with isolated deficiency of ter-
minal pathway activation (C6) exhibited a similar degree of protection to those with
more proximal interruption of the complement cascade (early complement component
C3 and intermediate component C5). This leads to the assumption, that formation of
the membrane attack complex ,the end product of the complement cascade to which
C6 and C7 contribute, is a critical mechanism through which complement mediates
renal postischemic injury.
An immediate neighbor of the complement component C3 is CFH, a regulator
of complement activation. Alexander and colleagues performed renal transplants be-
tween wildtype and CFH deficient mice and showed that CFH prevents the generation
of proinflammatory complement activation products [77]. Similar outcome could be
found when analyzing mice that lack a functional CD55, another complement regu-
latory protein and neighbor of CFH [78].
Two central nodes in the analysed graph component represent the transcription fac-
tor NFKB1 and the glucocorticoid receptor NR3C1. Both of these proteins are targets
for steroids as prednisolone for reducing systemic inflammation. Renal grafts from
marginal donors treated with prednisolone demonstrated a significantly improved
graft function [79]. At present Oberbauer et al. evaluate the impact of steroid treat-
ment of cadaveric donor kidneys on graft survival [80].
Among the LIV/CAD core set, holding 105 differentially regulated genes in living
and cadaveric donor kidneys, 96 genes could be mapped on the dependency graph.
Although the graph does not include all known proteins and is incomplete in terms
of splice variants, the interpretation of the LIV/CAD core set on the level of the
dependency graph offers further insights into the ongoing biological processes. The
results reinforce the findings that activation of the inflammation cascade is a main
cause of delayed graft function. Furthermore, they support donor immunosuppression
with steroids as an indication for therapeutic strategies. By all means, the depen-
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dency approach has the potential for triggering subsequent functional analysis on the
experimental level.
CONCLUSION AND OUTLOOK
This thesis presents two complementary analysis procedures of gene expression data.
Both approaches make use of statistical and functional classification methods, but
also provide aspects of protein-protein interactions. As input, data derived from
experimental analysis of PHN induced rat glomeruli, as well as of transplant donor
kidney biopsies was used.
The PHN dataset was analyzed following the sequential analysis workflow. The
procedure involved data pre-processing, clustering, statistical, functional, and protein
network analysis and resulted in a gene expression pattern that mainly goes inline
with previous work. Major findings were upregulated genes involved in cell structure,
cell motility, cell cycle, and in immunity and defense.
Transgelin, also known as SM22, showed the highest expression value associated
with PHN. The protein was found to be a repressor of the matrix metalloproteinase 9
(Mmp9) that is jointly responsible for degradation of extracellular matrix components.
Further inhibitors of metalloproteinases, Timp1 and Timp2, as well as Myh9 which
is involved in changes of cell morphology were shown to be upregulated in immunized
rats. Expression levels of cyclines as Ccnb1 or Ccnb2 and growthfactors like Tgfb also
separate healthy from diseased rats, thereby indicating a dysregulation of podocyte
proliferation.
The analysis of physical interactions between members of the core set of differen-
tially expressed genes supports the hypothesis of the critical relevance of the before
mentioned biological processes. The four identified clusters describe the main pro-
cesses in the glomerulus during the early phase of PHN that will lead to proteinuria.
These four processes are: (i) DNA damage and repair as seen in cluster 1; (ii) Changes
in the extracellular matrix; (iii) Deregulation of cytokines and growth factors and (iv)
Re-arrangement of the cytoskeleton.
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Subject of the integrated analysis workflow was the mapping of genes previously
identified as differentially regulated between living and cadaveric renal transplants,
on the level of a dependency graph. Dependencies between the objects were deter-
mined by four parameters, namely protein interaction, gene expression, function, and
subcellular location. Calculating shortest paths between members of the LIV/CAD
core set led to an extended set of genes potentially indicative for the development of
ARF and delayed graft function of transplants from cadaveric donors.
Most important results relate to members and regulators of the complement cas-
cade. The formation of a membrane attack complex and subsequent cellular lysis
can lead to ischemia reperfusion injury, a major cause of ARF. Another interesting
finding was the detection of strong functional dependencies of genes of the LIV/CAD
core set and targets for steroids, namely the transcription factor NFKB1 and the glu-
cocorticoid receptor NR3C1. Treatment of marginal donors with steroids is a clinical
approach to improve graft function.
In conclusion, an analysis of gene expression data on the level of a dependency
graph presents an improved expansion of the traditional sequential analysis workflow
in terms of deciphering functional relationships. Compared to solely statistical proce-
dures, the dependency graph approach follows the principal of integrating data from
different levels of observation, thereby enabling the elucidation of the overall state of
cells. These procedure promises the identification of potential biomarkers worth of
further experimental verification.
APPENDIX
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ABSTRACT
Background: Large scale differential gene expression profiling has provided a major
contribution to an extended analysis of cellular processes. However, interpretation
of such data for reaching a functional understanding of ongoing processes is a major
challenge, in particular when thinking in terms of a systems biology-driven analysis.
Following this concept, an integrated interpretation of expression profiles utilizing
broadly available additional ’omics’ sources promises a route for improved analysis
procedures.
Goals: This thesis exemplifies two workflows within the scope of computational
systems biology, applied on gene expression data characterizing the molecular basis of
diseases of the kidney. One workflow follows a sequential analysis procedure, centered
around a core set of differentially regulated genes derived on a purely statistical basis.
The second workflow in contrast uses an interaction network-based procedure.
Within this model intracellular interactions are represented as dependency graph
generated by integrating ’omics’ sources describing biological categories, tissue specific
gene expression, protein sub-cellular location, and known protein interactions. Gene
expression profiles are then interpreted on the level of this dependency graph.
Systems studied: Diseases of the kidney are a prevalent health issue, and under-
standing the pathophysiology might trigger improved diagnosis and therapy options.
This thesis focuses on an animal model for human membraneous nephropathy, and
second on mechanisms involved in kidney transplant failure. For both systems gene
expression data provided the basis for utilizing the data analysis workflows.
73
74
Results: For gene expression data characterizing membraneous nephropathy the
sequential analysis workflow was applied leading to the identification of 235 differ-
entially expressed genes. A functional classification of these features indicated the
disease associated involvement of changes in cell structure, cell cycle, as well as in
immunity and defense.
For expression profiles linked to transplant failure protein sub-networks linked to
immunity and defense, and here in particular members of the complement cascade
were found as key players.
Conclusions: Major challenges along ’omics’ based procedures have moved from ex-
perimental data generation to their functional interpretation. Diverse analysis work-
flow concepts are presently under development; their first data, however, clearly indi-
cate the potential of computational systems biology for providing an understanding
of complex cellular processes.
ZUSAMMENFASSUNG
Hintergrund: Das Erstellen von umfangreichen Genexpressionsprofilen lieferte
einen wesentlichen Beitrag zu erweiterten Analysen von zellula¨ren Prozessen. Die
Interpretation dieser Daten zielt auf ein funktionales Versta¨ndnis der biologischen
Prozesse ab und ist nach wie vor, insbesondere in Hinsicht auf eine systembiologische
Analyse, eine große Herausforderung. Diesem Konzept folgend verspricht eine Inter-
pretation der Expressionsprofile unter Einbeziehen von vorhandenen ’omics’ Daten
einen guten Ansatz fu¨r verbesserte Analysen.
Ziele: Diese Diplomarbeit erla¨utert zwei Arbeitsabla¨ufe aus dem Bereich der com-
puteruntersttzten Systembiologie, welche auf Genexpressionsdaten zur Charakter-
isierung der molekularen Prozesse in Nierenerkrankungen angewandt wurden. Einer
der Abla¨ufe ist eine sequentielle Analyse Prozedur, die sich mit differential regulierten
Genen aus einem rein statistischen Ansatz bescha¨ftigt.
Im Gegensatz dazu verwendet der zweite Ablauf Prozeduren basierend auf In-
teraktionsnetzwerken. Innerhalb dieses Modells werden die intrazellula¨ren Interak-
tionen durch Kanten eines Abha¨ngigkeitsgraphen repra¨sentiert. Die Gewichte dieser
Abha¨ngigkeiten werden durch Integration mehrerer ’omics’ Datenquellen berechnet,
die die Beschreibung biologischer Prozesse, gewebsspezifischer Genexpression, sub-
zellula¨rer Lokalisation von Proteinen und Proteininteraktionen inkludieren. Anhand
dieses Graphens wurden die Genexpresionsprofile interpretiert.
Untersuchte Systeme: Nierenerkrankungen stellen ein weitverbreitetes medi-
zinisches Problem dar. Das Versta¨ndnis ihrer Pathophysiologie ko¨nnte zu einer
verbesserten Diagnose und zur Ero¨ffnung weiterer Therapieoptionen fu¨hren. Diese
Diplomarbeit bescha¨ftigt sich zum einen mit einem Tiermodell der menschlichen mem-
brano¨sen Nephropathie und zum anderen mit Mechanismen, die zum Versagen von
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Nierentransplantaten fu¨hren. Beide angewandten Arbeitsabla¨ufe basieren auf Gen-
expressionsdaten der beschriebenen Krankheiten.
Resultate: Die sequentielle Analyse der Genexpressionsdaten, welche membrano¨se
Nephrities charakterisieren, fu¨hrte zur Identifikation von 235 differential regulierten
Genen. Eine funktionale Analyse der Gene zeigte, dass Vera¨nderungen in der
Zellstruktur, im Zellzyklus und auch in der Immunabwehr mit der Krankheit in
Verbindung stehen.
Die Subgraphen, die basierend auf den Genexpressionsprofil der Nierentransplan-
tate identifiziert werden konnten, waren stark mit Prozessen der Immunabwehr und
im speziellen, mit Komponenten des Komplementsystems, assoziiert.
Schlussfolgerungen: Die großen Herausforderungen die sich mit ’omics’ basieren-
den Prozeduren entwickelten, haben sich von Generation der Daten hin zu deren
funktionaler Interpretationen verschoben. Momentan entwickeln sich unterschiedliche
Analysekonzepte aber auch die schon vorhandenen Daten zeigen, dass die com-
puterunterstu¨tzte Systembiologie das Potential besitzt, das Versta¨ndnis komplexer
biologischer Prozesse voranzutreiben.
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